Alembic Pharmaceuticals Limited — Others, 05-08-2025: Shareholders meeting

Alembic Pharmaceuticals held its 15th Annual General Meeting via video conferencing, where shareholders adopted the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2025, and approved the declaration of dividend for FY24-25. Key resolutions passed include the re-appointment of Mr. Shaunak Amin as a Director, the appointment of Statutory Auditors, and the special resolutions for the appointment of Mr. Chirayu Amin as Executive Chairman and re-appointment of Mr. Pranav Amin as Managing Director. Other approvals included commission for Non-Executive Directors and auditor remunerations.